Montreal AI firms have secured over $2 billion in investments.
Many local manufacturers use advanced processes and tech to develop aerospace components.
Montreal is home to biotech companies ranging from medical device startups to globally known pharmaceutical firms.
Consulting companies work to optimize operations for clients, many of which work across the tech industry.
This latest investment will help the Canadian company innovate its sustainability reporting platform for enterprise organizations.
The facility will further AI development and feature a reduced environmental footprint.
The company provides management and payment solutions to parks, community centers and YMCAs across North America.
François Ravenelle joins the company with over two decades of pharmaceutical R&D experience.
The acquisition is expected to advance human-AI training capabilities.
Researchers will work to develop predictive algorithms that can help identify and correct data visualization errors in real time.
We're always looking for news.
